Early Access — free while we kick the tires
EdgarHawk

MPM BioVentures 2014, L.P.

1 filing analyzed · 1 company · Latest 2025-05-15

Companies

Company Buys Sells Direction
iTeos Therapeutics, Inc. ITOS 0 1 Net selling

Activity

May 2025
medium
Sell
630,191 shares
$5,079,339
Significance 6/10

MPM BioVentures sold 630,191 shares of ITOS at $8.06; still holds 2,108,594 shares post-transaction

MPM BioVentures 2014, L.P. sold 630,191 shares (23.0% reduction in holdings) at $8.06 on 2025-05-13, divesting $5,079,339.46 while retaining 2,108,594 shares. The sale occurred against a backdrop of substantial volatility: the stock has declined 55.9% from its 52-week high of $18.09 but posted a 34.3% gain over the prior 30 days. ITOS is pre-revenue (latest quarter revenue $0.00) with a full-year net loss of $-34,613,000.00, though revenue grew 177.9% year-over-year. The partial reduction in a major institutional holder's stake, while maintaining material exposure (2.11M shares remain), warrants monitoring as the company scales toward profitability and market validation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access